We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$125M
AUM Growth
-$7.44M
Cap. Flow
-$3.33M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.07%
Holding
82
New
4
Increased
37
Reduced
28
Closed
6

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$4.16M
2
INTC icon
Intel
INTC
+$2.09M
3
NTR icon
Nutrien
NTR
+$1.09M
4
BWA icon
BorgWarner
BWA
+$1.03M
5
DVN icon
Devon Energy
DVN
+$977K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.72%
2 Technology 15.13%
3 Healthcare 14.41%
4 Industrials 11.45%
5 Energy 11.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGZ icon
76
Vista Gold
VGZ
$253M
$6.25K 0.01%
11,200
AVNS icon
77
Avanos Medical
AVNS
$1.17B
-18,165
Closed -$437K
INTC icon
78
Intel
INTC
$466B
-89,119
Closed -$2.09M
LFCR icon
79
Lifecore Biomedical
LFCR
$162M
-22,410
Closed -$110K
MOS icon
80
The Mosaic Company
MOS
$7.09B
-12,240
Closed -$328K
SYNA icon
81
Synaptics
SYNA
$4.41B
-3,255
Closed -$253K
UL icon
82
Unilever
UL
$131B
-56,971
Closed -$4.16M

Similar funds

Keene & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Keene & Associates held 82 positions worth $125M, down 5.6% from $132M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Keene & Associates's Q4 2024 filing shows 4 new, 37 increased, 28 reduced and 6 closed positions. Its largest new stake was Jacobs Solutions: 22,469 shares worth $2.97M. The largest sale was Unilever, an estimated $4.16M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Keene & Associates's largest Q4 2024 buy was Jacobs Solutions: 22,469 shares worth $2.97M.
  • Keene & Associates added most to PIMCO Ultra Short Government Active ETF in Q4 2024, an estimated $993K increase.
  • Keene & Associates's biggest Q4 2024 reduction was Nutrien, cutting an estimated $1.09M.
  • Keene & Associates fully exited Unilever in Q4 2024, selling an estimated $4.16M.
  • Keene & Associates's ten largest holdings make up 34% of its $125M portfolio in Q4 2024.
  • Keene & Associates opened 4 new positions and closed 6 in Q4 2024.
  • Keene & Associates's portfolio value fell 5.6% quarter-over-quarter to $125M.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.